MXCT

MaxCyte, Inc.

MXCT · CIK 1287098 · Annual (10-K) · Last 4 years

Financial Trends

Revenue$39M
20212024
Net Income−$41M
20212024
Operating CF−$28M
20212024
Free Cash Flow−$29M
20212024

Income Statement

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕
Revenue$0.0B$0.0B$0.0B$0.0B
Cost of Revenue$0.0B$0.0B$0.0B$0.0B
Gross Profit$0.0B$0.0B$0.0B$0.0B
R&D Expense$0.0B$0.0B$0.0B$0.0B
SG&A Expense————
Operating Income$-0.1B$-0.0B$-0.0B$-0.0B
Net Income$-0.0B$-0.0B$-0.0B$-0.0B
EPS (Basic)$-0.39$-0.37$-0.23$-0.21
EPS (Diluted)$-0.39$-0.37$-0.23$-0.21

Balance Sheet

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕
Total Assets$0.2B$0.3B$0.3B$0.3B
Current Assets$0.2B$0.2B$0.3B$0.3B
Cash & Equivalents$0.0B$0.0B$0.0B$0.0B
Total Liabilities$0.0B$0.0B$0.0B$0.0B
Current Liabilities$0.0B$0.0B$0.0B$0.0B
Stockholders' Equity$0.2B$0.2B$0.3B$0.3B

Cash Flow Statement

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕
Operating Cash Flow$-0.0B$-0.0B$-0.0B$-0.0B
Investing Cash Flow$0.0B$0.1B$-0.0B$-0.2B
Capital Expenditures$0.0B$0.0B$0.0B$0.0B
Financing Cash Flow$0.0B$0.0B$0.0B$0.2B
← Companies